Complexes of palladium(II) with 1-phenyl-1-hydroxymethylene bisphosphonic acid and their antitumor activity / O. M. Kozachkova [et al.] // The Ukrainian Biochemical Journal. - 2017. - Том 89, N 2. - P106-115 MeSH-main: ПРОТИВООПУХОЛЕВЫЕ СРЕДСТВА -- ANTINEOPLASTIC AGENTS (терапевтическое применение) ПАЛЛАДИЙ -- PALLADIUM (терапевтическое применение) Annotation: Complex formation of K[[d]]2[[/d]][PdCl[[d]]4[[/d]]] with 1-phenyl-1-hydroxymethylene bisphosphonic acid (PhHMBP, H[[d]]4[[/d]]L) has been studied by pH potentiometry, electron and NMR spectroscopy. It was found that in aqueous solution with physiological concentration of chlorine anions (0.15 mol/l KCl), anionic complexes of the equimolar compositions [PdHLCl[[d]]2[[/d]]][[p]]3-[[/p]] (lgβ = 24.51 (0.3)) and [PdLCl[[d]]2[[/d]]][[p]]4- [[/p]](lgβ = 20.74 (0.02)) are formed. In the first coordination sphere palladium was surrounded by two oxygen atoms of two phosphonic groups of the bidentately coordinated ligand with closure of six-membered [O, O] ring, and two chlorine anions. The formation of palladium(II) equimolar complexes with PhHMBP and bidentate coordination of the ligand to the central metal cation was confirmed by[[p]] 31[[/p]]P NMR spectroscopy. Cytotoxic activity (IC[[d]]50[[/d]] based on metal content) of the synthesized Pd(II) complexes with PhHMBP against human MG-63 osteosarcoma and MCF-7 mammary tumor cells was compared with cisplatin on in vitro models. It was established that cytotoxic activity of the Pd complexes was lower than that of cisplatin. The acute toxicity (LD[[d]]50[[/d]] based on metal content) of solutions of Pd(II) complexes with PhHMBP was found to be lower compared to cisplatin. It was shown that the use of solutions of palladium(II) complexes with PhHMBP inhibited tumor growth in mice with sarcoma 180 Additional Access Points: Kozachkova, O. M. Tsaryk, N. V. Trachevskyi, V. V. Rozhenko, A. B. Shermolovich, Yu. H. Guzyr, O. I. Sharykina, N. I. Chekhun, V. F. Pekhnyo, V. I.